Daniel King

Daniel King is a Senior Principal Scientist at Novartis Institutes for BioMedical Research, with over a decade of experience in protein chemistry and drug discovery within the pharmaceutical industry. King has a proven track record in leading teams focused on the expression, purification, and characterization of recombinant proteins, as well as the development of biophysical assays for validating molecular interactions. Prior roles include Investigator III at Novartis, Research Scientist II at Pfizer, and positions at Wyeth Research, Dana Farber Cancer Institute, Harvard University, and Sarah Lawrence College, showcasing a robust background in both research and academic environments. King holds a degree in Chemistry from Boston University and further specialized training in Biochemistry and Biophysics from the University of Pennsylvania.